Upstream Bio, Inc (UPB) Diversifiers

Equity · Currency in USD · Last updated Jun 4, 2026

Upstream Bio, Inc. develops treatments for inflammatory diseases with a focus on severe respiratory disorders, including its product candidate verekitug, which is in clinical development for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease.

Looking to balance out your exposure to UPB? The ETFs below have the lowest correlation with UPB — they tend to move on their own, which can help reduce risk when UPB drops. The stock ideas table highlights individual companies that behave independently from UPB.

No Diversifiers Found for UPB

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements UPB

Add UPB to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with UPB